BMT is the best and permanent solution for Thalassemia and Sickle Cell Anaemia patients
KARIMNAGAR, DECEMBER 18, 2025: In a remarkable stride for blood cancer treatment, Yashoda Hospital, Somajiguda, Hyderabad, has successfully performed an Allogeneic Bone Marrow Transplant (BMT) on a 15-year-old boy patient hailing from Karimnagar district.
The Yashoda hospital had won accolades for successfully conducting more than 400 Bone Marrow transplantations on children and adults for the treatment of blood cancer. An allogeneic bone marrow transplant, where a patient receives healthy blood stem cells from a matched donor, is a successful, often life-saving treatment for blood cancers (like leukaemia, lymphoma) and non-cancerous blood disorders (like aplastic anaemia, HLH).
Disclosing this to newsmen at Yashoda health centre in Karimnagar town on Thursday, Hematologist and BMT expert Dr K Ashok Kumar said that the success rates are high (over 80% for aplastic anemia), with outcomes depending on the disease, match quality, patient health, and adherence to post-transplant care, involving strict infection control and nutrition for the new immune system to engraft.
Quoting high incidence of Thalassemia and Sickle Cell Anaemia cases among the children in the north Telangana region, Dr Ashok Kumar said the Bone Marrow Transplant, also known as stem cell transplant, is considered a potential cure and the only permanent cure currently available instead of monthly blood transfusion, which would cause heart and liver ailments due to accumulation of iron.
